Elevation of hepatic microsomal epoxide hydrolase activity by 2-acetylaminofluorene: strain and species differences
Identifieur interne : 001641 ( Main/Curation ); précédent : 001640; suivant : 001642Elevation of hepatic microsomal epoxide hydrolase activity by 2-acetylaminofluorene: strain and species differences
Auteurs : M. Elizabeth Graichen [États-Unis] ; John G. Dent [États-Unis]Source :
- Carcinogenesis [ 0143-3334 ] ; 1984.
Abstract
Hepatocarcinogens have been shown to cause marked elevation of hepatic microsomal epoxide hydrobase activity in the rat at short intervals after administration. The present studies were designed to characterize 2-acetylaminofluorene (AAF) mediated epoxide hydrolase elevation and to investigate the relationship between epoxide hydrolase increases, AAF metabolism, and hepatocarcinogenicity. Oral or i.p. administration of AAF to F-344 rats produced log-linear doseresponse curves for epoxide hydrolase elevation, measured with either benzo[a]pyrene-4, 5-oxide or styrene oxide substrate. Following a single dose of AAF (35 mg/kg), epoxide hydrolase activity was maximally increased (560% of control) within 48 h, and the activity declined slowly, with a halflife of 17.5 days. Co-treatment with actinomycin D effectively blocked the AAF dependent increase in epoxide hydrolase, suggesblng that de novo protein synthesis is associated with the increase in enzyme activity. Dose-response curves for epoxide hydrolase induction by AAF, N-hydroxy-2-acetylaminofluorene (N-OH-AAF), and aminofluorene were compared, and the potencies for increasing epoxide hydrolase activity reflected the relative hepatocarcinogenic potentials of these agents. In mice, which are resistant to the hepatocarcinogenic action of AAF and deficient in AAF-N-hydroxylase activity, AAF caused no significant increase in hepatic microsomal epoxide hydrolase activity. Similarly, in Cotton rats and guinea pigs, which are lacking in ability to form the sulfate conjugate of N-OH-AAF, neither i.p. nor dietary administration of AAF elicited increases in epoxide hydrolase activity at doses which were maximally effective in F-344 rats. These results support the hypothesis that the ability of compounds to increase epoxide hydrolase activity is related to their carcinogenic potency. Furthermore, the results suggest that increases in epoxide hydrolase activity are associated with metabolism of AAF to the putative proximate carcinogen N-OH-AAF, and the subsequent conversion of this compound to the N-O-sulfate conjugate.
Url:
DOI: 10.1093/carcin/5.1.23
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000710
- to stream Istex, to step Curation: Pour aller vers cette notice dans l'étape Curation :000690
- to stream Istex, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000768
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :001668
Links to Exploration step
ISTEX:C4D7642A7EC54BEC6FCFD43D17C98FA7B55C0C8CCuration
No country items
M. Elizabeth Graichen<affiliation><wicri:noCountry code="syntax">???</wicri:noCountry>
</affiliation>
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Elevation of hepatic microsomal epoxide hydrolase activity by 2-acetylaminofluorene: strain and species differences</title>
<author><name sortKey="Graichen, M Elizabeth" sort="Graichen, M Elizabeth" uniqKey="Graichen M" first="M. Elizabeth" last="Graichen">M. Elizabeth Graichen</name>
</author>
<author><name sortKey="Dent, John G" sort="Dent, John G" uniqKey="Dent J" first="John G." last="Dent">John G. Dent</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:C4D7642A7EC54BEC6FCFD43D17C98FA7B55C0C8C</idno>
<date when="1984" year="1984">1984</date>
<idno type="doi">10.1093/carcin/5.1.23</idno>
<idno type="url">https://api.istex.fr/ark:/67375/HXZ-QHK1WPD9-J/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000710</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000710</idno>
<idno type="wicri:Area/Istex/Curation">000690</idno>
<idno type="wicri:Area/Istex/Checkpoint">000768</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000768</idno>
<idno type="wicri:doubleKey">0143-3334:1984:Graichen M:elevation:of:hepatic</idno>
<idno type="wicri:Area/Main/Merge">001668</idno>
<idno type="wicri:Area/Main/Curation">001641</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Elevation of hepatic microsomal epoxide hydrolase activity by 2-acetylaminofluorene: strain and species differences</title>
<author><name sortKey="Graichen, M Elizabeth" sort="Graichen, M Elizabeth" uniqKey="Graichen M" first="M. Elizabeth" last="Graichen">M. Elizabeth Graichen</name>
<affiliation wicri:level="2"><country xml:lang="fr" wicri:curation="lc">États-Unis</country>
<wicri:regionArea>Department of Biochemical Toxicology, Chemical Industry Institute of Toxicology, Research Triangle Park, NC 27709</wicri:regionArea>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
<affiliation><wicri:noCountry code="syntax">???</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Dent, John G" sort="Dent, John G" uniqKey="Dent J" first="John G." last="Dent">John G. Dent</name>
<affiliation wicri:level="2"><country xml:lang="fr" wicri:curation="lc">États-Unis</country>
<wicri:regionArea>Department of Biochemical Toxicology, Chemical Industry Institute of Toxicology, Research Triangle Park, NC 27709</wicri:regionArea>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
<affiliation></affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Carcinogenesis</title>
<idno type="eISSN">1460-2180</idno>
<idno type="ISSN">0143-3334</idno>
<imprint><publisher>Oxford University Press</publisher>
<date when="1984-01">1984</date>
<biblScope unit="vol">5</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="23">23</biblScope>
<biblScope unit="page" to="28">28</biblScope>
</imprint>
<idno type="ISSN">0143-3334</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0143-3334</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract">Hepatocarcinogens have been shown to cause marked elevation of hepatic microsomal epoxide hydrobase activity in the rat at short intervals after administration. The present studies were designed to characterize 2-acetylaminofluorene (AAF) mediated epoxide hydrolase elevation and to investigate the relationship between epoxide hydrolase increases, AAF metabolism, and hepatocarcinogenicity. Oral or i.p. administration of AAF to F-344 rats produced log-linear doseresponse curves for epoxide hydrolase elevation, measured with either benzo[a]pyrene-4, 5-oxide or styrene oxide substrate. Following a single dose of AAF (35 mg/kg), epoxide hydrolase activity was maximally increased (560% of control) within 48 h, and the activity declined slowly, with a halflife of 17.5 days. Co-treatment with actinomycin D effectively blocked the AAF dependent increase in epoxide hydrolase, suggesblng that de novo protein synthesis is associated with the increase in enzyme activity. Dose-response curves for epoxide hydrolase induction by AAF, N-hydroxy-2-acetylaminofluorene (N-OH-AAF), and aminofluorene were compared, and the potencies for increasing epoxide hydrolase activity reflected the relative hepatocarcinogenic potentials of these agents. In mice, which are resistant to the hepatocarcinogenic action of AAF and deficient in AAF-N-hydroxylase activity, AAF caused no significant increase in hepatic microsomal epoxide hydrolase activity. Similarly, in Cotton rats and guinea pigs, which are lacking in ability to form the sulfate conjugate of N-OH-AAF, neither i.p. nor dietary administration of AAF elicited increases in epoxide hydrolase activity at doses which were maximally effective in F-344 rats. These results support the hypothesis that the ability of compounds to increase epoxide hydrolase activity is related to their carcinogenic potency. Furthermore, the results suggest that increases in epoxide hydrolase activity are associated with metabolism of AAF to the putative proximate carcinogen N-OH-AAF, and the subsequent conversion of this compound to the N-O-sulfate conjugate.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001641 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 001641 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= CovidV1 |flux= Main |étape= Curation |type= RBID |clé= ISTEX:C4D7642A7EC54BEC6FCFD43D17C98FA7B55C0C8C |texte= Elevation of hepatic microsomal epoxide hydrolase activity by 2-acetylaminofluorene: strain and species differences }}
This area was generated with Dilib version V0.6.33. |